VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.
Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma. JCI Insight. 2019 03 07; 4(5).
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Animals
Cell Line, Tumor
Disease Models, Animal
Electron Transport Complex I
Female
Glucose
Glucose Transporter Type 1
Glycolysis
Humans
Hypoxia
Immunotherapy
Lymphocyte Activation
Male
Melanoma
Melanoma, Experimental
Mice
Mice, Inbred C57BL
Mice, Knockout
Middle Aged
Oxidative Stress
Programmed Cell Death 1 Receptor
Prospective Studies
T-Lymphocytes
Tumor Microenvironment
authors with profiles
JOHN KIRKWOOD